Pharmafile Logo

News and Press Releases

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024

Upperton Pharma Solutions
contact@upperton.com
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

Viroclinics-DDL Changes Name to Cerba Research

14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...

Category: Biotechnology, Clinical Trials
Posted: March 15, 2024

Cerba Research
Klaartestraat 20, 9052 Ghent, Belgium

ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC for Ground-breaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology

13 March 2024 -- Berlin, Germany -- ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, is pleased to announce the execution of services and license agreements...

Category: Biotechnology
Posted: March 13, 2024

ProBioGen
info@probiogen.de
Herbert-Bayer-Straße 8 13086 Berlin

Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes

5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...

Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024

Pill Connect
info@pill-connect.con
125 Deansgate, Manchester, M2 3BY, UK

Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Globally operating CDMO committed to strengthening Germany as a research and production location  Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...

Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024

Vetter
Schützenstrasse 87, 88212 Ravensburg

New partnership aims to advance vaccine against MERS coronavirus

CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...

Category: Clinical Trials
Posted: January 2, 2024

Barinthus Biotherapeutics
Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF

Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe

30 November 2023 -- Bengaluru, India -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that the integration of the Viatris’ biosimilars business in 31 European countries has been successfully...

Category: Pharmaceutical
Posted: November 30, 2023

Biocon Biologics
contact@bioconbiologics.com
Biocon House, Semicon Park Electronics City, Phase – II, Hosur Road Bengaluru 560100, Karnataka, India

Additional Analytical Laboratory and Spray Drying Investments

5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...

Category: Manufacturing and Packing
Posted: October 5, 2023

Experic
info@expericservices.com
2 Clarke Drive, Cranbury, NJ 08512

Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023

New exploratory analysis of phase 3 SCORPIO-SR study data in Asia suggests that ensitrelvir may reduce the risk of persistent and new late-onset symptoms associated with long COVID-19 over one...

Category: Clinical Trials
Posted: September 20, 2023

SHIONOGI
contact@shionogi.eu
33 Kingsway, London, WC2B 6UF, UK